Argatroban in extracorporeal membrane oxygenation

Artificial Organs

Volumn 31, Issue 6, 2007, Pages 461-465

  Beiderlinden, Martin ^a,b   Treschan, Tanja ^a   Görlinger, Klaus ^a   Peters, Jürgen ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Acute renal failure; Acute respiratory distress syndrome; Anticoagulation; Heparin induced thrombocytopenia; Indocyanine green; Liver function

Indexed keywords

FIGHTER AIRCRAFT; MANUFACTURE; OXYGENATION; POLYSACCHARIDES; RESPIRATORY THERAPY;

ACUTE RENAL FAILURE; ACUTE RESPIRATORY DISTRESS SYNDROME; ANTI-COAGULATION; ARGATROBAN; EXTRACORPOREAL MEMBRANE OXYGENATION; HEPARIN-INDUCED THROMBOCYTOPENIUM; INDOCYANINE GREEN; LIVER FUNCTIONS; RENAL FAILURE; THROMBOCYTOPENIA;

ENZYMES;

ARGATROBAN; HEPARIN; THROMBIN INHIBITOR;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; EXTRACORPOREAL OXYGENATION; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; OXYGENATOR; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOSIS;

EID: 34249325483     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2007.00388.x     Document Type: Article

References (20)

1. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996 101 : 502 7.
2. Nand S, Wong W, Yuen B, Yetter A, Schmulbach E, Gross Fischer S. Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution. Am J Hematol 1997 56 : 12 6.
3. Greinacher A, Volpel H, Janssens U, et al. Potzsch B, for the HIT investigators group. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. Circulation 1999 99 : 73 80.
4. Horsewood P, Warkentin TE, Hayward CP, Kelton JG. The epitope specificity of heparin-induced thrombocytopenia. Br J Haematol 1996 95 : 161 7.
5. Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001 344 : 1286 92.
6. Wallis DE, Workman DL, Lewis BE, Steen L, Pifarre R, Moran JF. Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. Am J Med 1999 106 : 629 35.
7. Lubenow N, Greinacher A. Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin. J Thromb Thrombolysis 2000 10 : S47 57.
8. Lewis BE, Wallis DE, Berkowitz SD, et al. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 2001 103 : 1838 43.
9. Di Nisio M, Middeldorp S, Büller HR. Direct thrombin inhibitors. N Engl J Med 2005 353 : 1028 40.
10. Murray PT, Reddy BV, Grossman EJ, et al. A prospective comparison of three argatroban regimens during hemodialysis in end-stage renal disease. Kidney Int 2004 66 : 2446 53.
11. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994 149 : 818 24.
12. Available at: http://us.gsk.com/products/assets/us_argatroban.pdf.
13. Sakka SG, Reinhart K, Meier-Hellmann A. Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest 2002 122 : 1715 20.
14. Williamson DR, Boulanger I, Tardif M, Albert M, Grégoire G. Argatroban dosing in intensive care patients with acute renal failure and liver dysfunction. Pharmacotherapy 2004 24 : 409 14.
15. Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996 22 : 707 10.
16. Pollack DS, Sulfian S, Matsumoto T. Indocyanine green clearance in critically ill patients. Surg Gynecol Obstet 1979 149 : 852 4.
17. Terenaka M, Schenk WG. Hepatic blood flow measurement. A comparison of the indocyanine green and electromagnetic techniques normal and abnormal flow states in the dog. Ann Surg 1977 185 : 58 63.
18. Wesslau C, Krüger R, May G. Clinical investigations using indocyanine green clearance for evaluation of liver function in organ donors. Transplantology 1994 5 : 1 3.
19. Oellerich M, Burdelski M, Lautz HU, et al. Assessment of pretransplant prognosis in patients with cirrhosis. Transplantation 1991 51 : 801 6.
20. Hemming AW, Scudamore CH, Shackleton CR. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 1992 163 : 515 8.